IBM forms 16-member international collaborative to speed development of products that diagnose patients correctly first time

IBM Watson Health is extending net to supply its artificial intelligence system by coming up with a 16-member international unit of health systems, academic medical centers and imaging technology companies to boost the development speed of products that diagnose patients rightly in the first time. IBM said that ranging from rural America's hospitals and academic medical centers in the inner city to Europe and Japan's imaging companies the collaborative will expand its effort to spot the major problems of the healthcare in'real-life' settings in daily practice. The Watson Health business presently has data on nearly 300 million patients and the collaborative is going to help record the experience of doctors and imaging centers working with numerous distinct diseases and imaging equipment used in the treatment of patients. In an interview, Steven Tolle, chief strategy officer for Watson Health Imaging, said that the collaborative is going to assist doctors in addressing different cancers such as breast and lung and also eye health, diabetes, and brain and heart diseases. Further, Tolle gave assurance to IBM Watson's observers that the collaborative is going to be wider than its rivals. While speaking about IBM Watson rivals, Tolle said, "They partner with one partner and go after one disease.